Physician profile
Katarzyna Trebska
NPI 1902198815
$9,692.69
in general payments reported to CMS, 2019-2025
57 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.30 · 2021: $513 · 2022: $2,271 · 2023: $2,249 · 2024: $3,022 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,698 · Travel and Lodging: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,697.80 |
| Travel and Lodging | $190.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $1,987.86 | 2022-2024 | Magseed, Magtrace |
| Stryker Corporation | $1,304.85 | 2022-2025 | Molli, Spy-Phi System |
| Astrazeneca Pharmaceuticals LP | $723.65 | 2022-2025 | Lynparza, Imfinzi, Enhertu |
| Merck Sharp & Dohme LLC | $628.97 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Leica Microsystems INC. | $493.51 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $492.57 | 2022-2025 | |
| Daiichi Sankyo INC. | $384.50 | 2022-2025 | Enhertu, Datroway, Injectafer |
| Eisai INC. | $289.96 | 2020-2025 | |
| Hologic INC | $246.71 | 2021-2022 | |
| Janssen Biotech, INC. | $194.01 | 2022-2025 | Rybrevant, Tecvayli, Talvey |
| Pfizer INC. | $189.74 | 2022-2025 | |
| Seagen INC. | $177.60 | 2022-2023 | Tukysa, Padcev, Adcetris |
| Aveo Pharmaceuticals, INC. | $136.28 | 2022-2025 | Fotivda |
| Regeneron Healthcare Solutions, INC. | $133.62 | 2023-2025 | Libtayo |
| Incyte Corporation | $128.94 | 2022-2025 | Jakafi, Pemazyre, Monjuvi |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarzyna Trebska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.